Cargando…

Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis

Infections in patients with cirrhosis are common among those who develop variceal hemorrhage. Prophylactic antimicrobial treatment with third generation cephalosporins is recommended in patients with advanced cirrhosis and gastrointestinal hemorrhage. However no infectious source is identified in up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sack, Jordan, Peaper, David R., Mistry, Pramod, Malinis, Maricar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133649/ https://www.ncbi.nlm.nih.gov/pubmed/27920982 http://dx.doi.org/10.1016/j.idcr.2016.11.008

Ejemplares similares

The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system
por: Narayanan, Praveena, et al.
Publicado: (2022)

535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
por: Palacios, Carlo Foppiano, et al.
Publicado: (2022)

A Case of Bordetella bronchiseptica Bacteremia in a Patient With Decompensated Liver Cirrhosis
por: Chan, Kok Hoe, et al.
Publicado: (2021)

Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis
por: Tocia, Cristina, et al.
Publicado: (2020)

The Value of Antimicrobial Stewardship Team (AST) in Conjunction with Infectious Diseases Consult in Reducing the 30-day Mortality of Patients with Staphylococcus aureus Bacteremia in a Single Academic Medical Center
por: Sherbuk, Jacqueline, et al.
Publicado: (2017)

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China
por: Shen, Zi-Xuan, et al.
Publicado: (2022)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
por: Kandula, Manasa, et al.
Publicado: (2016)

Cryptococcal Peritonitis in a Patient with Decompensated Liver Cirrhosis
por: Libera, Robert, et al.
Publicado: (2023)

Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis
por: Jiang, Qun-Qun, et al.
Publicado: (2018)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series
por: Prodanovic, Hélène, et al.
Publicado: (2007)

Decompensated Cirrhosis after Renal Transplantation: A Case Report
por: Patel, Vinay, et al.
Publicado: (2011)

A Case Report of Decompensated Cirrhosis of Liver with Sideroblastic Anemia
por: Mahtab, Mamun-Al, et al.
Publicado: (2015)

Acute Brucellosis and Cirrhosis: The Triggering Event of Fatal Liver Decompensation
por: Kosmidou, Maria, et al.
Publicado: (2020)

Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis: A prospective study
por: Jha, Ashish Kumar, et al.
Publicado: (2017)

Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2020)

Multiple infarcted regenerative nodules in liver cirrhosis after decompensation of cirrhosis: a case series
por: Scholtze, Dieter, et al.
Publicado: (2010)

Clostridioides difficile Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
por: Dungan, William, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Opportunistic peritonitis in peritoneal dialysis: The example of Paracoccus yeei
por: Fosso, Christelle, et al.
Publicado: (2021)

Pest categorisation of Paracoccus marginatus
por: Bragard, Claude, et al.
Publicado: (2023)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy
por: Premkumar, Madhumita, et al.
Publicado: (2012)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Safe Use of POEM in a Patient With Decompensated Cirrhosis and Severe Achalasia
por: Loh, Rebecca, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8cr8apg3tn98v97m3tfkses2lv